1. Home
  2. FNV vs BDX Comparison

FNV vs BDX Comparison

Compare FNV & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franco-Nevada Corporation

FNV

Franco-Nevada Corporation

HOLD

Current Price

$232.96

Market Cap

43.6B

ML Signal

HOLD

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

HOLD

Current Price

$180.77

Market Cap

43.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNV
BDX
Founded
1986
1897
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.6B
43.0B
IPO Year
2009
1998

Fundamental Metrics

Financial Performance
Metric
FNV
BDX
Price
$232.96
$180.77
Analyst Decision
Buy
Buy
Analyst Count
8
13
Target Price
$248.13
$186.00
AVG Volume (30 Days)
720.1K
1.7M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
0.69%
2.89%
EPS Growth
N/A
N/A
EPS
N/A
1.59
Revenue
N/A
$21,840,000,000.00
Revenue This Year
$55.98
N/A
Revenue Next Year
$16.81
$3.02
P/E Ratio
$53.29
$114.52
Revenue Growth
N/A
8.24
52 Week Low
$173.84
$140.11
52 Week High
$285.67
$213.08

Technical Indicators

Market Signals
Indicator
FNV
BDX
Relative Strength Index (RSI) 60.26 72.35
Support Level $220.92 $163.44
Resistance Level $241.73 $187.35
Average True Range (ATR) 6.33 4.05
MACD 1.16 0.73
Stochastic Oscillator 70.08 87.84

Price Performance

Historical Comparison
FNV
BDX

About FNV Franco-Nevada Corporation

Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. The company's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project.

About BDX Becton Dickinson and Company

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Share on Social Networks: